Some items on our site have recently moved. Visit our News Hub for selected articles, special reports, podcasts and other resources.
Jenna Ebersole
Correspondent
Jenna comes to MLex as an M&A correspondent after nearly two years at Law360, including one year as senior reporter for telecommunications. She has past experience as an investigative data researcher at LegiStorm. Jenna graduated from Boston University with a degree in English and has also worked as a local news reporter in Pennsylvania and North Dakota.
Selected Insights by Jenna
-
US antitrust policy hasn’t seen major shifts in enforcement between presidential administrations in decades. -
A revised merger-remedies manual doubles down on antitrust chief Makan Delrahim’s strong preference for divestitures. -
US Attorney General Bill Barr last year ordered the in-depth probe of a cannabis industry merger that later collapsed, overruling Justice Department staff. -
The call for a merger moratorium due to the novel coronavirus pandemic likely won’t become law. -
Pharmaceutical industry mergers traditionally fall in the US Federal Trade Commission’s bailiwick, but the US Department of Justice over the last year has instead pushed to review some of those deals, along with other deals customarily examined by the FTC, MLex has learned.